Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Neuronetics Inc

STIM ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: BUY

Last Close

$3.30

▲ +8.91%

Market Cap $251.45M · Vol 626.90K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$251.45M

Micro Cap

Div Yield

N/A

EPS Growth

+26.55%

YoY

RSI (14)

78.99

Momentum

Beta

1.27

vs Market

52W High

$3.78

12.70% below

52W Low

$0.80

312.50% above

Volume

626.90K

Avg 626.73K

P/B

4.25

Price-to-book

ROE

N/A

Return on equity

Free Float

44.82%

Public shares

Shariah Compliance8 STANDARDS

✗ Neuronetics Inc (STIM) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does STIM pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+38.66%

+86.44%

+153.85%

+132.39%

YTD

+139.13%

-7.30%

+83.33%

-60.99%

Financials & Valuation

TTM · Annual

Total Revenue	$149.16M
Net Income	$-39,135,000.00
Revenue Growth (YoY)	+9.08%
Gross Margin	48.48%
Operating Margin	-21.08%
Net Profit Margin	-26.24%
ROE	N/A
ROA · ROIC	-27.71% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.61
P/B	4.25
P/FCF	N/A
EPS Growth	+26.55%
Outstanding Shares	76.20M

Technical Indicators

50-Day SMA	$1.76
200-Day SMA	$1.65
RSI (14)	78.99
Beta	1.27
52-Week High	$3.78
52-Week Low	$0.80

Volume Today	626.90K
Avg Daily Volume (30D)	626.73K
Relative Volume	1.00x
Volatility (10D)	199.10
Volatility (30D)	148.35
Free Float	44.82%

Analyst Consensus

BUY

Current Price $3.30

Mean Target $6.00

52W Low$0.80 52W High$3.78

Current

Target

$0.80 $3.78

Current Analyst target

+81.82% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SSSWY7

ISINUS64131A1051

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 8, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.